BioSpace News Archive

The global reprocessed medical devices market has been growing at a healthy pace and is likely to generate potential growth opportunities for the market players.

The global telehealth market is anticipated to expand at a CAGR of 13.0% within the forecast period of 2017 to 2025.

Retinitis pigmentosa is a medical condition inherited, which causes retinal degeneration.

Invetx, a pioneering animal health biopharmaceutical company, announced a $15 million Series A financing and founding collaborations with WuXi Biologics and AbCellera.

ASLAN Pharmaceuticals Limited announced its presentation at the 9th Annual SVB Leerink Global Healthcare Conference.

Businesses across China need to secure epidemic supplies such as face masks and disinfectant to re-open factories and offices.

Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced that it has entered into a research collaboration with GSK for its protein-based coronavirus vaccine candidate.

Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that aggregated results from 309 children treated with Ryoncil™ (remestemcel-L) were presented at the American Society for Transplantation Cellular Therapy and the Center for International Blood & Bone Marrow Transplant Research (TCT) meeting in Orlando, Florida on February 22.

United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the INCREASE clinical study of Tyvaso® (treprostinil) Inhalation Solution in patients suffering from World Health Organization (WHO)

Karius, the world leader in liquid biopsy for infectious diseases, secured $165 million in a new funding round led by SoftBank Vision Fund 21, with additional participation from General Catalyst, HBM Healthcare Investments, and existing investors Khosla Ventures and LightSpeed Venture Partners